close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Talis Biomedical Corporation

Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash
From Talis Biomedical Corporation
Via GlobeNewswire
Tickers TLIS
Talis Biomedical Announces Second Quarter 2023 Financial Results and Business Update
From Talis Biomedical Corporation
Via GlobeNewswire
Tickers TLIS
Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023
From Talis Biomedical Corporation
Via GlobeNewswire
Tickers TLIS
Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)
From Talis Biomedical Corporation
Via GlobeNewswire
Tickers TLIS
New Data Presented at the Infectious Disease Society for Obstetrics and Gynecology (IDSOG) Annual Meeting Differentiate Talis Biomedical’s Women’s and Sexual Health Product Menu
From Talis Biomedical Corporation
Via GlobeNewswire
Tickers TLIS
Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price Requirement
From Talis Biomedical Corporation
Via GlobeNewswire
Tickers TLIS
Talis Biomedical Announces 1-for-15 Reverse Stock Split
From Talis Biomedical Corporation
Via GlobeNewswire
Tickers TLIS
Talis Biomedical Appoints Former Roche Molecular CEO Heiner Dreismann to Board of Directors, Announces Former Genomic Health CEO Kim Popovits as Lead Independent Director
From Talis Biomedical Corporation
Via GlobeNewswire
Tickers TLIS
Talis Biomedical Announces Business Update and First Quarter 2023 Financial Results
From Talis Biomedical Corporation
Via GlobeNewswire
Tickers TLIS
Talis Biomedical to Provide Business Update and Financial Results on May 11, 2023
From Talis Biomedical Corporation
Via GlobeNewswire
Tickers TLIS
Talis Announces Fourth Quarter and Full Year 2022 Financial Results
From Talis Biomedical Corporation
Via GlobeNewswire
Tickers TLIS
Talis Biomedical Reports Third Quarter 2022 Financial Results
From Talis Biomedical Corporation
Via GlobeNewswire
Tickers TLIS
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today